Discusses new treatment strategies for malignant mesothelioma, pulmonary edema, fibrosis, asthma, emphysema, and bronchiectasis.
Proteoglycans in Lung Disease considers
glycosaminoglycans as novel therapeutic agents or targets in lung diseasethe role of proteoglycans in determining mechanical behavior of lung tissuehyaluronan and its receptors in wound healing, inflammation, vasculogenesis, and angiogenesisthe impact of small proteoglycans on matrix assemblyversican as a modulator of cell adhesion, migration, and proliferationantiproliferative activity of heparin and its derivatives on pulmonary artery smooth muscle cellsthe effects of mechanical strain on proteoglycansthe functions of proteoglycans in the vascular wallthe effect of hypoxia on glycosaminoglycans in the lung
Comprised of more than 1940 references, Proteoglycans in Lung Disease
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.